UPDATE: Dawson James Initiates Coverage on Ariad Pharmaceuticals with Market Outperform Rating, $32 PT
UPDATE: Dawson James Initiates Pharmacyclics at Market Outperform on Ibrutinib Confidence
UPDATE: Dawson James Downgrades The GEO Group to Market Perform on Valuation
UPDATE: Dawson James Initiates Spectrum Pharmaceuticals at Market Outperform on Share Weakness
Dawson James Recent News
UPDATE: Dawson James Initiates Affymax at Market Outperform on Momentum
UPDATE: Dawson James Initiates Astex Pharmaceuticals at Market Outperform
UPDATE: Dawson James Initiates Celsion at Market Outperform on Phase III Catalyst
UPDATE: Dawson James Initiates Rockwell Medical at Market Outperform on Execution
UPDATE: Dawson James Initiates Cytokinetics at Market Outperform on Competitive Positioning
UPDATE: Dawson James Reiterates Buy Rating, Lowers PT on Galectin Therapeutics
Will Comcast and Verizon Crush Netflix?
Elephant Talk Communications Initiated with Buy at Dawson James
Coverage Initiated On: (EFX, GME, BBT, ECOL, VRTX)